

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 5.40435804 |
| 2 | positive regulation of cellular amide metabolic process (GO:0034250) | 5.05364103 |
| 3 | endothelial cell chemotaxis (GO:0035767) | 4.91502396 |
| 4 | T-helper 1 type immune response (GO:0042088) | 4.75312517 |
| 5 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 4.58589995 |
| 6 | regulation of superoxide anion generation (GO:0032928) | 4.52703761 |
| 7 | * amino sugar catabolic process (GO:0046348) | 4.50627120 |
| 8 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 4.47631556 |
| 9 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.38184662 |
| 10 | surfactant homeostasis (GO:0043129) | 4.33963240 |
| 11 | positive regulation of p38MAPK cascade (GO:1900745) | 4.21898877 |
| 12 | glycosphingolipid catabolic process (GO:0046479) | 4.17557854 |
| 13 | regulation of phospholipase A2 activity (GO:0032429) | 4.10091785 |
| 14 | macrophage differentiation (GO:0030225) | 3.89384406 |
| 15 | venous blood vessel morphogenesis (GO:0048845) | 3.84709890 |
| 16 | coronary vasculature morphogenesis (GO:0060977) | 3.80928180 |
| 17 | regulation of beta-amyloid formation (GO:1902003) | 3.78963006 |
| 18 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.73807190 |
| 19 | positive regulation of bone resorption (GO:0045780) | 3.73651724 |
| 20 | positive regulation of bone remodeling (GO:0046852) | 3.73651724 |
| 21 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.73542191 |
| 22 | glycolipid catabolic process (GO:0019377) | 3.72638226 |
| 23 | detection of molecule of bacterial origin (GO:0032490) | 3.65991944 |
| 24 | oligosaccharide catabolic process (GO:0009313) | 3.54209895 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.45285452 |
| 26 | regulation of endothelial cell chemotaxis (GO:2001026) | 3.43118762 |
| 27 | detection of external biotic stimulus (GO:0098581) | 3.41049797 |
| 28 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 3.38476611 |
| 29 | regulation of cholesterol storage (GO:0010885) | 3.38266581 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.36183197 |
| 31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.35972241 |
| 32 | detection of other organism (GO:0098543) | 3.33878688 |
| 33 | * glucosamine-containing compound catabolic process (GO:1901072) | 3.33087662 |
| 34 | positive regulation of protein kinase C signaling (GO:0090037) | 3.29873645 |
| 35 | ceramide catabolic process (GO:0046514) | 3.29772684 |
| 36 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.28186136 |
| 37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.20231559 |
| 38 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.19219904 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 3.16784584 |
| 40 | detection of bacterium (GO:0016045) | 3.13207145 |
| 41 | negative regulation of bone resorption (GO:0045779) | 3.12930761 |
| 42 | response to thyroid hormone (GO:0097066) | 3.09068610 |
| 43 | chemical homeostasis within a tissue (GO:0048875) | 3.08811075 |
| 44 | response to peptidoglycan (GO:0032494) | 3.08005187 |
| 45 | detection of biotic stimulus (GO:0009595) | 3.03959647 |
| 46 | microglial cell activation (GO:0001774) | 3.01376207 |
| 47 | regulation of p38MAPK cascade (GO:1900744) | 3.01267432 |
| 48 | barbed-end actin filament capping (GO:0051016) | 2.97589225 |
| 49 | positive regulation of cholesterol efflux (GO:0010875) | 2.94488304 |
| 50 | regulation of superoxide metabolic process (GO:0090322) | 2.94429480 |
| 51 | positive regulation of vascular permeability (GO:0043117) | 2.89471596 |
| 52 | negative regulation of cell killing (GO:0031342) | 2.89213482 |
| 53 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.89213482 |
| 54 | macrophage activation (GO:0042116) | 2.88253994 |
| 55 | neutrophil activation involved in immune response (GO:0002283) | 2.87534592 |
| 56 | regulation of cholesterol esterification (GO:0010872) | 2.87193371 |
| 57 | cellular extravasation (GO:0045123) | 2.86816750 |
| 58 | regulation of cellular amide metabolic process (GO:0034248) | 2.86287860 |
| 59 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.85901047 |
| 60 | phospholipid efflux (GO:0033700) | 2.83433723 |
| 61 | regulation of bone resorption (GO:0045124) | 2.82377047 |
| 62 | granulocyte chemotaxis (GO:0071621) | 2.77626430 |
| 63 | negative regulation of tissue remodeling (GO:0034104) | 2.77071467 |
| 64 | apoptotic cell clearance (GO:0043277) | 2.73156882 |
| 65 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.72072248 |
| 66 | adenosine receptor signaling pathway (GO:0001973) | 2.70741406 |
| 67 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.69291921 |
| 68 | positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737) | 2.68690389 |
| 69 | granulocyte migration (GO:0097530) | 2.67421078 |
| 70 | positive regulation of histone deacetylation (GO:0031065) | 2.65579473 |
| 71 | positive regulation of macrophage cytokine production (GO:0060907) | 2.65495689 |
| 72 | mannose metabolic process (GO:0006013) | 2.64168163 |
| 73 | positive regulation of axon extension (GO:0045773) | 2.63834751 |
| 74 | immunoglobulin mediated immune response (GO:0016064) | 2.62315160 |
| 75 | positive regulation of extracellular matrix organization (GO:1903055) | 2.53789143 |
| 76 | peptide catabolic process (GO:0043171) | 2.53337111 |
| 77 | astrocyte differentiation (GO:0048708) | 2.52780862 |
| 78 | phagosome maturation (GO:0090382) | 2.52188800 |
| 79 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.52154031 |
| 80 | positive regulation of sterol transport (GO:0032373) | 2.50440166 |
| 81 | positive regulation of cholesterol transport (GO:0032376) | 2.50440166 |
| 82 | lung vasculature development (GO:0060426) | 2.49895914 |
| 83 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.49318433 |
| 84 | membrane lipid catabolic process (GO:0046466) | 2.48939061 |
| 85 | negative regulation of interleukin-12 production (GO:0032695) | 2.48537410 |
| 86 | sphingolipid catabolic process (GO:0030149) | 2.48307124 |
| 87 | regulation of macrophage cytokine production (GO:0010935) | 2.45466255 |
| 88 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.45459938 |
| 89 | positive regulation of tissue remodeling (GO:0034105) | 2.45300909 |
| 90 | positive regulation of antigen processing and presentation (GO:0002579) | 2.45024839 |
| 91 | protein localization to endosome (GO:0036010) | 2.44391339 |
| 92 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.44249829 |
| 93 | complement activation, classical pathway (GO:0006958) | 2.42591587 |
| 94 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.41976731 |
| 95 | eosinophil chemotaxis (GO:0048245) | 2.41959654 |
| 96 | positive regulation by symbiont of host defense response (GO:0052509) | 2.41401920 |
| 97 | modulation by symbiont of host defense response (GO:0052031) | 2.41401920 |
| 98 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.41401920 |
| 99 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.41401920 |
| 100 | modulation by symbiont of host immune response (GO:0052553) | 2.41401920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.79130164 |
| 2 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.70173868 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.69157511 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.18388386 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.85935355 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.60322015 |
| 7 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.44719444 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.42228450 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32011560 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.29524347 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.26645329 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.26000680 |
| 13 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.18427588 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.12878614 |
| 15 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.03526323 |
| 16 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.03210603 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.98175809 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.90691063 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 1.82112704 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.78513972 |
| 21 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.76405556 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72516152 |
| 23 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.72091123 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71759877 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.69959081 |
| 26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.69944867 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68921272 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.67119715 |
| 29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.62768978 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60893502 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.56637662 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.49879440 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.46419041 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43983441 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38521484 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36754807 |
| 37 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.36648909 |
| 38 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36612170 |
| 39 | KDM2B_26808549_Chip-Seq_K562_Human | 1.29152501 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28708706 |
| 41 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.28376310 |
| 42 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27645633 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.26250177 |
| 44 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24203488 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21584542 |
| 46 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.20375422 |
| 47 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.19308890 |
| 48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17388355 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.16574059 |
| 50 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.16230487 |
| 51 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14959726 |
| 52 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13172674 |
| 53 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13012857 |
| 54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12567939 |
| 55 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12499998 |
| 56 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.12045592 |
| 57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11888646 |
| 58 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11301274 |
| 59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.10832265 |
| 60 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09021163 |
| 61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08022809 |
| 62 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.06483774 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06170681 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05233619 |
| 65 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.04579767 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03936863 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02968759 |
| 68 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99796726 |
| 69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99032129 |
| 70 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.98932419 |
| 71 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94880855 |
| 72 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.94777968 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94507437 |
| 74 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.94191801 |
| 75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93556478 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93306749 |
| 77 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93251506 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90883087 |
| 79 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89363914 |
| 80 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.89335065 |
| 81 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88878043 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88600524 |
| 83 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.88350817 |
| 84 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.88350817 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88172696 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87758711 |
| 87 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87444542 |
| 88 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87354152 |
| 89 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87172745 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85872218 |
| 91 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85839372 |
| 92 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.85587165 |
| 93 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83514605 |
| 94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83006262 |
| 95 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.81393973 |
| 96 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.81333022 |
| 97 | MAF_26560356_Chip-Seq_TH1_Human | 0.78846684 |
| 98 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77371142 |
| 99 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.76684604 |
| 100 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.76058066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 4.24665853 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.76137668 |
| 3 | MP0000604_amyloidosis | 3.69967127 |
| 4 | MP0003329_amyloid_beta_deposits | 3.40752583 |
| 5 | MP0009840_abnormal_foam_cell | 3.33045477 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 3.25222341 |
| 7 | MP0003303_peritoneal_inflammation | 3.00395119 |
| 8 | MP0003172_abnormal_lysosome_physiology | 2.85535681 |
| 9 | MP0006082_CNS_inflammation | 2.82059490 |
| 10 | MP0003724_increased_susceptibility_to | 2.77314177 |
| 11 | MP0003436_decreased_susceptibility_to | 2.65961210 |
| 12 | MP0003690_abnormal_glial_cell | 2.59506282 |
| 13 | MP0009278_abnormal_bone_marrow | 2.45199613 |
| 14 | MP0000343_altered_response_to | 2.29334138 |
| 15 | MP0005167_abnormal_blood-brain_barrier | 2.29125761 |
| 16 | MP0001853_heart_inflammation | 2.22778414 |
| 17 | * MP0002419_abnormal_innate_immunity | 2.21566802 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.16714289 |
| 19 | MP0003075_altered_response_to | 2.13394763 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.08703565 |
| 21 | MP0009785_altered_susceptibility_to | 2.02557037 |
| 22 | MP0001835_abnormal_antigen_presentation | 1.98422680 |
| 23 | MP0002998_abnormal_bone_remodeling | 1.82136672 |
| 24 | MP0001790_abnormal_immune_system | 1.81073978 |
| 25 | MP0005387_immune_system_phenotype | 1.81073978 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.79109626 |
| 27 | MP0003195_calcinosis | 1.77983624 |
| 28 | MP0005025_abnormal_response_to | 1.76933664 |
| 29 | MP0009384_cardiac_valve_regurgitation | 1.72542686 |
| 30 | MP0003279_aneurysm | 1.72159222 |
| 31 | MP0003091_abnormal_cell_migration | 1.70491460 |
| 32 | MP0000920_abnormal_myelination | 1.61970357 |
| 33 | MP0000678_abnormal_parathyroid_gland | 1.61938584 |
| 34 | MP0000685_abnormal_immune_system | 1.57309005 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.56829136 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.49627040 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.49014919 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.49014919 |
| 39 | MP0005671_abnormal_response_to | 1.48113208 |
| 40 | MP0008775_abnormal_heart_ventricle | 1.45569186 |
| 41 | MP0008260_abnormal_autophagy | 1.41637421 |
| 42 | MP0001958_emphysema | 1.38456006 |
| 43 | * MP0002452_abnormal_antigen_presenting | 1.36561431 |
| 44 | MP0003634_abnormal_glial_cell | 1.35693459 |
| 45 | MP0009764_decreased_sensitivity_to | 1.33543519 |
| 46 | MP0005166_decreased_susceptibility_to | 1.30338288 |
| 47 | MP0004947_skin_inflammation | 1.27522815 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.27444084 |
| 49 | MP0004883_abnormal_blood_vessel | 1.25281207 |
| 50 | * MP0002723_abnormal_immune_serum | 1.25251777 |
| 51 | MP0005164_abnormal_response_to | 1.24671405 |
| 52 | MP0004510_myositis | 1.24101344 |
| 53 | MP0005257_abnormal_intraocular_pressure | 1.21822345 |
| 54 | MP0005023_abnormal_wound_healing | 1.18800247 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.10953798 |
| 56 | MP0008469_abnormal_protein_level | 1.10458078 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.10044701 |
| 58 | * MP0001800_abnormal_humoral_immune | 1.09502446 |
| 59 | MP0002877_abnormal_melanocyte_morpholog | 1.09323678 |
| 60 | MP0003448_altered_tumor_morphology | 1.09283803 |
| 61 | MP0005451_abnormal_body_composition | 1.07329840 |
| 62 | MP0001849_ear_inflammation | 1.06167832 |
| 63 | MP0005365_abnormal_bile_salt | 1.05878257 |
| 64 | MP0000747_muscle_weakness | 1.04916839 |
| 65 | * MP0002420_abnormal_adaptive_immunity | 1.01166126 |
| 66 | * MP0001819_abnormal_immune_cell | 1.00263915 |
| 67 | MP0002405_respiratory_system_inflammati | 0.96955571 |
| 68 | MP0000249_abnormal_blood_vessel | 0.96826924 |
| 69 | MP0002139_abnormal_hepatobiliary_system | 0.94862238 |
| 70 | MP0004233_abnormal_muscle_weight | 0.94446875 |
| 71 | MP0003632_abnormal_nervous_system | 0.94232927 |
| 72 | MP0005165_increased_susceptibility_to | 0.93908943 |
| 73 | MP0003828_pulmonary_edema | 0.93310334 |
| 74 | MP0003795_abnormal_bone_structure | 0.88606449 |
| 75 | MP0005595_abnormal_vascular_smooth | 0.88129731 |
| 76 | MP0002254_reproductive_system_inflammat | 0.86544337 |
| 77 | MP0005388_respiratory_system_phenotype | 0.86529627 |
| 78 | MP0002133_abnormal_respiratory_system | 0.86529627 |
| 79 | MP0005390_skeleton_phenotype | 0.83465887 |
| 80 | MP0002933_joint_inflammation | 0.83278407 |
| 81 | MP0000383_abnormal_hair_follicle | 0.81189986 |
| 82 | MP0003045_fibrosis | 0.79043979 |
| 83 | MP0001879_abnormal_lymphatic_vessel | 0.78380017 |
| 84 | MP0010155_abnormal_intestine_physiology | 0.78282564 |
| 85 | MP0003633_abnormal_nervous_system | 0.77803350 |
| 86 | MP0004858_abnormal_nervous_system | 0.76996190 |
| 87 | MP0008438_abnormal_cutaneous_collagen | 0.76508870 |
| 88 | MP0002896_abnormal_bone_mineralization | 0.75676319 |
| 89 | MP0000579_abnormal_nail_morphology | 0.74103396 |
| 90 | MP0009763_increased_sensitivity_to | 0.70447122 |
| 91 | MP0004084_abnormal_cardiac_muscle | 0.70219753 |
| 92 | MP0002090_abnormal_vision | 0.69774214 |
| 93 | MP0003566_abnormal_cell_adhesion | 0.69272398 |
| 94 | MP0000858_altered_metastatic_potential | 0.69190638 |
| 95 | MP0005310_abnormal_salivary_gland | 0.67401478 |
| 96 | MP0001440_abnormal_grooming_behavior | 0.65898784 |
| 97 | MP0003631_nervous_system_phenotype | 0.65200022 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.64964030 |
| 99 | MP0008874_decreased_physiological_sensi | 0.63950262 |
| 100 | * MP0009333_abnormal_splenocyte_physiolog | 0.63012863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.40014649 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.40014649 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 7.40014649 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 5.99065004 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 4.96746599 |
| 6 | Neurofibrillary tangles (HP:0002185) | 4.45267060 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.10373881 |
| 8 | Glomerulonephritis (HP:0000099) | 4.10231153 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.98567316 |
| 10 | Dysostosis multiplex (HP:0000943) | 3.92977155 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 3.91852177 |
| 12 | Loss of speech (HP:0002371) | 3.89868673 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.77604512 |
| 14 | Complement deficiency (HP:0004431) | 3.76257933 |
| 15 | Axonal loss (HP:0003447) | 3.62035954 |
| 16 | Myocardial infarction (HP:0001658) | 3.52320383 |
| 17 | Disinhibition (HP:0000734) | 3.29425334 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.26360245 |
| 19 | Cerebral inclusion bodies (HP:0100314) | 3.21262559 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.20756317 |
| 21 | Abnormality of complement system (HP:0005339) | 3.14781972 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 3.14621873 |
| 23 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.04567568 |
| 24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.04567568 |
| 25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.04567568 |
| 26 | Mucopolysacchariduria (HP:0008155) | 2.97543284 |
| 27 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.97543284 |
| 28 | Purpura (HP:0000979) | 2.87330354 |
| 29 | Orchitis (HP:0100796) | 2.85889664 |
| 30 | Mutism (HP:0002300) | 2.74655375 |
| 31 | Myositis (HP:0100614) | 2.68980008 |
| 32 | Amyloidosis (HP:0011034) | 2.63942701 |
| 33 | Upper motor neuron abnormality (HP:0002127) | 2.54066209 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 2.53556535 |
| 35 | Xanthomatosis (HP:0000991) | 2.53044326 |
| 36 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.52830881 |
| 37 | Cerebral aneurysm (HP:0004944) | 2.51642789 |
| 38 | Increased CSF protein (HP:0002922) | 2.51633761 |
| 39 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.50203656 |
| 40 | Apathy (HP:0000741) | 2.49983819 |
| 41 | Turricephaly (HP:0000262) | 2.46154416 |
| 42 | Diminished motivation (HP:0000745) | 2.45619871 |
| 43 | Retrobulbar optic neuritis (HP:0100654) | 2.45457893 |
| 44 | Optic neuritis (HP:0100653) | 2.45457893 |
| 45 | Nephritis (HP:0000123) | 2.44516583 |
| 46 | Vertebral compression fractures (HP:0002953) | 2.37635361 |
| 47 | Neuronal loss in central nervous system (HP:0002529) | 2.34480103 |
| 48 | Hyperacusis (HP:0010780) | 2.26829486 |
| 49 | Obstructive sleep apnea (HP:0002870) | 2.25544530 |
| 50 | Hepatosplenomegaly (HP:0001433) | 2.23690824 |
| 51 | Nuclear cataract (HP:0100018) | 2.22872969 |
| 52 | Dementia (HP:0000726) | 2.21475025 |
| 53 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.13019704 |
| 54 | Interstitial pulmonary disease (HP:0006530) | 2.12811752 |
| 55 | Basal ganglia calcification (HP:0002135) | 2.12413614 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.11779177 |
| 57 | Gingivitis (HP:0000230) | 2.11003901 |
| 58 | Supranuclear gaze palsy (HP:0000605) | 2.08643866 |
| 59 | Abnormality of the periventricular white matter (HP:0002518) | 2.08071340 |
| 60 | Pathologic fracture (HP:0002756) | 2.03551889 |
| 61 | Increased variability in muscle fiber diameter (HP:0003557) | 2.03505119 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.01461730 |
| 63 | Obstructive lung disease (HP:0006536) | 2.01461730 |
| 64 | Cardiomegaly (HP:0001640) | 2.00897862 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.00420721 |
| 66 | Progressive neurologic deterioration (HP:0002344) | 1.99281104 |
| 67 | Recurrent skin infections (HP:0001581) | 1.99208183 |
| 68 | Bone pain (HP:0002653) | 1.98331747 |
| 69 | Peripheral demyelination (HP:0011096) | 1.95655635 |
| 70 | Skin nodule (HP:0200036) | 1.94327214 |
| 71 | J-shaped sella turcica (HP:0002680) | 1.93097589 |
| 72 | Agnosia (HP:0010524) | 1.90126562 |
| 73 | Protuberant abdomen (HP:0001538) | 1.86395077 |
| 74 | Asymmetric septal hypertrophy (HP:0001670) | 1.83812543 |
| 75 | Elfin facies (HP:0004428) | 1.83249145 |
| 76 | Thin bony cortex (HP:0002753) | 1.82384022 |
| 77 | Hemoptysis (HP:0002105) | 1.81915381 |
| 78 | Increased IgE level (HP:0003212) | 1.81741787 |
| 79 | Restrictive lung disease (HP:0002091) | 1.79319175 |
| 80 | Retinal atrophy (HP:0001105) | 1.77163809 |
| 81 | Abnormality of the endocardium (HP:0004306) | 1.73858227 |
| 82 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.72386130 |
| 83 | Poor head control (HP:0002421) | 1.72026516 |
| 84 | Alveolar cell carcinoma (HP:0006519) | 1.71584759 |
| 85 | Spontaneous hematomas (HP:0007420) | 1.69181993 |
| 86 | Gastrointestinal infarctions (HP:0005244) | 1.67389770 |
| 87 | Recurrent fungal infections (HP:0002841) | 1.67079146 |
| 88 | Overriding aorta (HP:0002623) | 1.66320041 |
| 89 | Insomnia (HP:0100785) | 1.65976928 |
| 90 | Prolonged neonatal jaundice (HP:0006579) | 1.65812140 |
| 91 | Increased serum ferritin (HP:0003281) | 1.64268103 |
| 92 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.63467389 |
| 93 | Personality changes (HP:0000751) | 1.62548281 |
| 94 | Mesangial abnormality (HP:0001966) | 1.61967752 |
| 95 | Global brain atrophy (HP:0002283) | 1.61786867 |
| 96 | Keratoconjunctivitis sicca (HP:0001097) | 1.60616844 |
| 97 | Inappropriate behavior (HP:0000719) | 1.60363359 |
| 98 | Cellulitis (HP:0100658) | 1.60280558 |
| 99 | Renovascular hypertension (HP:0100817) | 1.59723465 |
| 100 | Pulmonary embolism (HP:0002204) | 1.58962192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERBB4 | 5.65930410 |
| 2 | BLK | 3.14646540 |
| 3 | ERN1 | 3.13916869 |
| 4 | TYK2 | 2.93281179 |
| 5 | TRIB3 | 2.72982202 |
| 6 | FGFR4 | 2.36432989 |
| 7 | IRAK3 | 2.35345884 |
| 8 | RIPK4 | 1.97217492 |
| 9 | RIPK1 | 1.92736147 |
| 10 | PKN1 | 1.91140082 |
| 11 | NEK9 | 1.79654683 |
| 12 | MAP3K3 | 1.70450141 |
| 13 | PDGFRA | 1.67765368 |
| 14 | JAK1 | 1.67195127 |
| 15 | CSK | 1.62865343 |
| 16 | ZAP70 | 1.61501169 |
| 17 | JAK2 | 1.60370273 |
| 18 | MAP3K13 | 1.56632266 |
| 19 | FES | 1.54681196 |
| 20 | EPHB1 | 1.53484071 |
| 21 | EPHA3 | 1.52922062 |
| 22 | DDR2 | 1.50713138 |
| 23 | MAPK11 | 1.46451256 |
| 24 | TYRO3 | 1.46214259 |
| 25 | KIT | 1.45095169 |
| 26 | TGFBR2 | 1.44592398 |
| 27 | TBK1 | 1.37962007 |
| 28 | MAPK15 | 1.34298842 |
| 29 | PRPF4B | 1.33596073 |
| 30 | ERBB2 | 1.31680113 |
| 31 | MAP3K14 | 1.28812001 |
| 32 | CDC42BPA | 1.27532577 |
| 33 | FGFR3 | 1.23600117 |
| 34 | IRAK4 | 1.10340882 |
| 35 | MAP2K3 | 1.10330399 |
| 36 | FGR | 1.10085519 |
| 37 | JAK3 | 1.08877333 |
| 38 | ABL2 | 1.08773214 |
| 39 | PDGFRB | 1.04612778 |
| 40 | KSR2 | 1.03455567 |
| 41 | MAP3K6 | 0.99947621 |
| 42 | NTRK1 | 0.94500849 |
| 43 | CAMK2G | 0.92257094 |
| 44 | PKN2 | 0.91626107 |
| 45 | PDPK1 | 0.91585014 |
| 46 | NTRK3 | 0.87854771 |
| 47 | ROCK2 | 0.87458382 |
| 48 | IKBKE | 0.86456482 |
| 49 | MAP3K1 | 0.85023691 |
| 50 | CSF1R | 0.84875444 |
| 51 | HCK | 0.82993076 |
| 52 | NEK6 | 0.82399151 |
| 53 | LIMK1 | 0.82251909 |
| 54 | LYN | 0.81200333 |
| 55 | MOS | 0.78497090 |
| 56 | RET | 0.76921598 |
| 57 | CAMKK2 | 0.76211176 |
| 58 | SYK | 0.73698882 |
| 59 | CAMKK1 | 0.72946954 |
| 60 | GRK7 | 0.70930863 |
| 61 | CAMK1D | 0.70434652 |
| 62 | TNK2 | 0.68513618 |
| 63 | MAPK12 | 0.68242928 |
| 64 | PRKD2 | 0.67683348 |
| 65 | MAP4K1 | 0.66904481 |
| 66 | IRAK1 | 0.66319943 |
| 67 | RPS6KA2 | 0.65693432 |
| 68 | LATS2 | 0.65619264 |
| 69 | MARK2 | 0.64077668 |
| 70 | PDK2 | 0.63385271 |
| 71 | MAPK7 | 0.63094781 |
| 72 | MAP3K11 | 0.62823604 |
| 73 | SIK1 | 0.61682195 |
| 74 | TAOK2 | 0.61344332 |
| 75 | TAOK1 | 0.61248627 |
| 76 | MAPK4 | 0.60435883 |
| 77 | PTK2 | 0.59282476 |
| 78 | NTRK2 | 0.57646731 |
| 79 | ABL1 | 0.56689131 |
| 80 | PRKD1 | 0.54725566 |
| 81 | TESK2 | 0.54277375 |
| 82 | FYN | 0.52571603 |
| 83 | LCK | 0.52434088 |
| 84 | TESK1 | 0.51862322 |
| 85 | PDK1 | 0.51590704 |
| 86 | PAK4 | 0.50180414 |
| 87 | SRC | 0.49022386 |
| 88 | NME2 | 0.44717676 |
| 89 | CAMK1G | 0.44126514 |
| 90 | BMX | 0.43659541 |
| 91 | ARAF | 0.43248740 |
| 92 | GSK3A | 0.42813590 |
| 93 | PTK6 | 0.42723222 |
| 94 | MATK | 0.42017537 |
| 95 | TTN | 0.41994105 |
| 96 | SMG1 | 0.40481354 |
| 97 | PRKCH | 0.40402202 |
| 98 | IKBKB | 0.39276374 |
| 99 | MAPKAPK2 | 0.38916703 |
| 100 | ROCK1 | 0.37915079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.37836052 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.34129874 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 3.17033109 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.51828012 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.27061254 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.19314700 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.18167870 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.17929679 |
| 9 | Phagosome_Homo sapiens_hsa04145 | 2.10313994 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.88421481 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.88376651 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.75856206 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.70151471 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 1.69831396 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.65041447 |
| 16 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.64063975 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.61091720 |
| 18 | Bladder cancer_Homo sapiens_hsa05219 | 1.59872878 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.51584810 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.50914371 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.50425689 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.49252530 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.46863241 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45575273 |
| 25 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.40350125 |
| 26 | Prion diseases_Homo sapiens_hsa05020 | 1.39119253 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28143215 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24834544 |
| 29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.20595605 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14684718 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.14119059 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12652364 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.11738584 |
| 34 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.11542149 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10094324 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04152857 |
| 37 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.03925006 |
| 38 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02042343 |
| 39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00074086 |
| 40 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99719993 |
| 41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94946558 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.94608474 |
| 43 | Amoebiasis_Homo sapiens_hsa05146 | 0.94290762 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 0.94181831 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 0.93901651 |
| 46 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93366608 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.91292332 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.90501440 |
| 49 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88516732 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.87435951 |
| 51 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.86689504 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84191798 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84050836 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.82823773 |
| 55 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.81978871 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81792098 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79033215 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78739462 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74491547 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74309028 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73296163 |
| 62 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71615632 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71137076 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69828836 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66164361 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.66145264 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65275018 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63996249 |
| 69 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.63610705 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63602353 |
| 71 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62207359 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.61929856 |
| 73 | Focal adhesion_Homo sapiens_hsa04510 | 0.60425414 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59250073 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59001718 |
| 76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58695208 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58475661 |
| 78 | Measles_Homo sapiens_hsa05162 | 0.58105148 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57993294 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.56800750 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55605868 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.54204291 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51877318 |
| 84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49752184 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48689330 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48220053 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44388443 |
| 88 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.44085875 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.43631975 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.43502263 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42635908 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41087694 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.40783423 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39931090 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39884132 |
| 96 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.39760088 |
| 97 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38318315 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37957959 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35122732 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | 0.33870506 |

